REDWOOD CITY, Calif.--(BUSINESS WIRE)--Karius, Inc., a life sciences company focused on conquering infectious diseases, today announced that the company has raised $50 million in Series A equity ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Karius®, Inc., a leader in genomic diagnostics for infectious diseases, announced today that the Karius Test® has been granted designation as a Breakthrough ...
Please provide your email address to receive an email when new articles are posted on . The manufacturer of the Karius Test is seeking to market it for diagnosing lung infections in immunocompromised ...
After picking up $100 million in venture capital cash earlier this month, Karius is adding another feather to its cap with a breakthrough designation from the FDA. The company’s DNA-based blood test ...
REDWOOD CITY, Calif., Aug. 3, 2020 /PRNewswire/ -- Karius, the world leader in liquid biopsy for infectious diseases, announced today active enrollment in a multicenter, prospective study that will ...
The infectious disease diagnostic developer Karius has secured another $100 million to help expand the reach of its microbial DNA test designed to detect more than 1,000 different pathogens from a ...
Karius is helping doctors identify infections early among the most vulnerable patients, redrawing the liquid biopsy space along the way. Before the current pandemic, it was more difficult to observe ...
A baby admitted to a hospital in Texas goes through a complete workup for infectious disease and other potential causes of disease. The clinicians at that children’s hospital concluded that there is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback